FDA approves Novartis radioligand therapy Pluvicto for earlier use before chemotherapy in PSMA-positive metastatic castration-resistant prostate cancer
Ad hoc announcement pursuant to Art. 53 LR New indication approximately triples…
Novartis receives third FDA approval for oral Fabhalta (iptacopan) the first and only treatment approved in C3 glomerulopathy (C3G)
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first…
Enlivex Receives Notice of Allowance for Chinese Patent Application Covering the Use of Allocetra in Patients with Osteoarthritis
March 17, 2025 08:00 ET | Source: Enlivex Therapeutics Ltd Nes-Ziona, Israel,…
Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD
Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five…
GHIT-backed Innovation Achieves Landmark: New Treatment Option for Schistosomiasis Reaches Preschool-Aged Children
TOKYO, March 5, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund…
Forbes and U.S. News & World Report Agree: HealthEquity is One of Americas Best Places to Work
Forbes recognized HealthEquity as one of America’s Dream Employers for 2025, while…
MediBeacon Transdermal GFR System receives device approval in China; Peer-reviewed articles on MediBeacon technology published
Transdermal GFR System (TGFR) is a first-in-kind product for point of care…
Hospital shooting highlights the dangers and violence nurses often face at work
SILVER SPRING, MD, Feb. 22, 2025 (GLOBE NEWSWIRE) -- SILVER SPRING, MD…
Onco360 Has Been Selected as a National Specialty Pharmacy Partner for GOMEKLI (mirdametinib), Manufactured By SpringWorks Therapeutics
LOUISVILLE, Ky., Feb. 17, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading…
Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and Older
First chikungunya vaccine approved for persons as young as 12 years old,…